Interferon-λ structure and antiviral activity: research advances

JIN Wei-wei,YAO Wen-bing,XU Chen
DOI: https://doi.org/10.13220/j.cnki.jipr.2013.03.015
2013-01-01
Abstract:Interferon λ(IFN-λ),also called type Ⅲ interferon,is a new cytokine discovered recently.By binding with its specific two dimer receptor complexes(IFN-λ R1 / IL-10R2),IFN-λ can mediate JAK-STAT signal transduction pathway and induce the body's antiviral response,thereby exerting its antiviral effect.IFN-λ receptors distribution has certain histological specificity.In clinical trials of chronic hepatitis C,IFN-λ is well tolerated and has no serious side effects of blood and nervous system inhibition.This paper focuses on the recent progress in IFN-λ gene and protein structure,IFN-λ / IFN-λ R1 binding sites,in vivo and in vitro antiviral activity,and its role in clinical treatment of hepatitis C.
What problem does this paper attempt to address?